Baxter to Host Fourth-Quarter 2024 Financial Results Conference Call for Investors
Baxter International (NYSE:BAX), a global medtech leader, has announced it will host a conference call to discuss its fourth-quarter 2024 financial results on Thursday, February 13, 2025 at 7:30 a.m. Central Time. Investors can pre-register for the call through a provided registration link. The conference call will also be accessible via webcast through Baxter's website. The company notes that the call will be recorded and is copyrighted material, requiring Baxter's permission for any recording or rebroadcasting.
Baxter International (NYSE:BAX), un leader globale nel settore medtech, ha annunciato che ospiterà una conferenza telefonica per discutere i suoi risultati finanziari del quarto trimestre 2024 il giovedì 13 febbraio 2025 alle 7:30 ora centrale. Gli investitori possono preregistrarsi per la chiamata attraverso un link di registrazione fornito. La conferenza telefonica sarà anche accessibile tramite webcast sul sito web di Baxter. L'azienda sottolinea che la chiamata sarà registrata e costituisce materiale protetto da copyright, richiedendo il permesso di Baxter per qualsiasi registrazione o riproduzione.
Baxter International (NYSE:BAX), un líder global en tecnología médica, ha anunciado que realizará una llamada de conferencia para discutir sus resultados financieros del cuarto trimestre de 2024 el jueves 13 de febrero de 2025 a las 7:30 a.m., hora central. Los inversores pueden preregistrarse para la llamada a través de un enlace de registro proporcionado. La llamada de conferencia también será accesible a través de un webcast en el sitio web de Baxter. La empresa señala que la llamada será grabada y es material protegido por derechos de autor, requiriendo el permiso de Baxter para cualquier grabación o retransmisión.
Baxter International (NYSE:BAX), 글로벌 메드텍 리더, 는 2024년 4분기 재무 결과에 대해 논의하기 위해 회의 전화를 개최할 것이라고 발표했습니다. 회의 전화는 2025년 2월 13일 목요일 오전 7시 30분 중앙 시간에 진행됩니다. 투자자들은 제공된 등록 링크를 통해 미리 등록할 수 있습니다. 또한 회의 전화는 Baxter의 웹사이트를 통해 웹캐스트로도 접근할 수 있습니다. 회사는 이 전화가 녹음될 것이며 저작권 자료로 보호되어 있어 어떠한 녹음이나 재방송에 대해서도 Baxter의 허가가 필요하다고 언급했습니다.
Baxter International (NYSE:BAX), un leader mondial dans le secteur des technologies médicales, a annoncé qu'il tiendrait une conférence téléphonique pour discuter de ses résultats financiers du quatrième trimestre 2024 le jeudi 13 février 2025 à 7h30, heure centrale. Les investisseurs peuvent se préinscrire pour l'appel via un lien d'inscription fourni. La conférence téléphonique sera également accessible par webcast via le site Web de Baxter. L'entreprise souligne que l'appel sera enregistré et qu'il s'agit d'un matériel protégé par le droit d'auteur, nécessitant l'autorisation de Baxter pour toute enregistrement ou rediffusion.
Baxter International (NYSE:BAX), ein führendes Unternehmen im Bereich Medizintechnik, hat angekündigt, einen Konferenzanruf abzuhalten, um über seine Finanzergebnisse für das vierte Quartal 2024 zu diskutieren. Dieser findet am Donnerstag, den 13. Februar 2025 um 7:30 Uhr zentraler Zeit statt. Investoren können sich über einen bereitgestellten Registrierungslink für den Anruf vorregistrieren. Der Konferenzanruf wird auch über ein Webcast auf der Webseite von Baxter zugänglich sein. Das Unternehmen weist darauf hin, dass der Anruf aufgezeichnet wird und urheberrechtlich geschütztes Material ist, was die Erlaubnis von Baxter für jede Aufzeichnung oder Ausstrahlung erforderlich macht.
- None.
- None.
This call is also being webcast and can be accessed through Baxter’s website at www.baxter.com. The conference call will be recorded by Baxter and is copyrighted material. It cannot be recorded or rebroadcast without Baxter’s permission.
About Baxter
Every day, millions of patients and caregivers rely on Baxter’s leading portfolio of diagnostic, critical care, kidney care, nutrition, hospital and surgical products used across patient homes, hospitals, physician offices and other sites of care. For more than 90 years, we’ve been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen. With products, digital health solutions and therapies available in more than 100 countries, Baxter’s employees worldwide are now building upon the company’s rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations. To learn more, visit www.baxter.com and follow us on X, LinkedIn and Facebook.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250122392790/en/
Media Contact
Steve Brett, (224) 948-5353
media@baxter.com
Investor Contact
Clare Trachtman, (224) 948-3020
Source: Baxter International Inc.
FAQ
When will Baxter (BAX) release its Q4 2024 earnings?
What time is Baxter's (BAX) Q4 2024 earnings call?
How can investors join Baxter's (BAX) Q4 2024 earnings call?